| [1] |
邓俊丽，张蕊，唐洁，等. 他汀类药物抗肿瘤作用的研究进展[J]. 中国临床药理学与治疗学， 2017, 22(1): 92-99.
|
| [2] |
谢抒睿，徐本华．他汀类药物在直肠癌新辅助放化疗中的研究进展[J]．中华放射肿瘤学杂志，2019，28(5): 394-397.
|
| [3] |
Fitzmaurice C, Allen C, Barber RM，et al.Global，regional，and national cancer incidence，mortality，years of life lost，years lived with disability，and disability-adjusted life-years for 32 cancer groups，1990 to 2015: a systematic analysis for the global burden of disease study global burden[J]．JAMA Oncol，2017，3(4): 524-548.
|
| [4] |
Lagergren J, Smyth E, Cunningham D，et al. Oesophageal cancer [J]．Lancet，2017，390(10110): 2383-2396.
|
| [5] |
Coleman HG, Xie SH, Lagergren J. The-epidemiology-of-esophageal- adenocarcinoma[J]．Gastroenterology，2018，154(2): 390-405.
|
| [6] |
Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma[J]．Gastroenterology，2018，154(2): 360-373.
|
| [7] |
Spence AD, Busby J, Johnston BT，et al. Low-dose aspirin use does not increase survival in 2 independent population-based cohorts of patients with esophageal or gastric cancer[J]．Gastroenterology, 2018，154(4): 849-860.
|
| [8] |
Theresa Nguyen, Anam Khan, Yan Liu，et al. the Association Between Statin use After diagnosis and Mortality risk in Patients With Esophageal cancer：A retrospective cohort Study of united States Veterans[J] .Am J Gastroenterol，2018，113(9): 1310.
|
| [9] |
Nguyen DM, Richardson P, El-Serag HB.Medications(NSAIDs，statins，proton pump inhibitors)and the risk of esophageal adenocar-cinoma in patients with Barrett's esophagus[J]. Gastroenterology，2010，138(7): 2260-2266.
|
| [10] |
Olivia Lacroix, Alexandra Couttenier1, Evelien Vaes，et al. Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study[J]. Cancer Causes Control，2019，30(4): 385-393.
|
| [11] |
Tom Thomas, Yoon Loke, Ian LP，et al. Systematic Review and Meta-analysis: Use of Statins Is Associated with a Reduced Incidence of Esophageal Adenocarcinoma[J]．J Gastrointest Cancer，2018，49(4): 442-454.
|
| [12] |
Liang D, Liang S, Jin J，et al. Gastric cancer burden of last 40 years in North China(Hebei Province)：a population-based study[J]. Medicine(Baltimore)，2017，96(2): e5887.
|
| [13] |
Singh PP, Singh S．Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis[J]．Ann Oncol，2013，24(7): 1721-1730.
|
| [14] |
Nielsen SF, Nordestgaard BG, Bojesen SE. Statin use and reduced cancer-related mortality[J]. N Engl J Med，2012，367(19): 1792-1802.
|
| [15] |
Andrew D. Spence, John Busby, Carmel M. Hughes，et al. Statin use and survival in patients with gastric cancer in two independent population-based cohorts[J]．Pharmacoepidemiology and Drug Safety，2019，28(4): 460-470.
|
| [16] |
Shi M, Zheng H, Nie B，et al. Statin use and risk of liver cancer: an update meta-analysis[J]．BMJ Open 2014，4: e005399.
|
| [17] |
Aaron P. Thrift, Yamini Natarajan, Yan Liu，et al. Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality[J]. Clin Gastroenterol Hepatol ，2019，17(10): 2117-2125.
|
| [18] |
Katherine A. McGlynn, Katrina Hagberg，et al. Statin Use and Risk of Primary Liver Cancer in the Clinical Practice Research Datalink[J]. J Natl Cancer Inst，2015，107(4): djv009.
|
| [19] |
Wu Li-Li , Hsieh Mao-Chih, PhD，et al. Statins improve outcomes of nonsurgical curative treatments in hepatocellular carcinoma patients[J]. Medicine，2016，95(36): 1-11.
|
| [20] |
Konstantinos P, Konstantinos Stavropoulos, Michael Doumas，et al. The potential role of statins in treating liverdisease[J]．Exp Rev Gastroenterol Hepatol，2018，12(1): 1-9.
|
| [21] |
Singh S, Singh PP, Roberts LR，et al. Chemopreventive strategies in hepatocellular carcinoma[J]. Nat Rev Gastroenterol Hepatol，2014，11(1): 45-54.
|
| [22] |
Valle JW, lamarca a, goyal l，et al. new Horizons for precision medicine in biliary tract cancers[J]．Cancer Discov，2017，7(9): 943-962.
|
| [23] |
王葵，沈丰．肝内胆管癌的诊治进展[J]．肝胆外科杂志，2019，1(1): 1-6.
|
| [24] |
liu Z, alsaggaf r, Mcglynn Ka，et al. Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Data link [J]．Gut，2019，68(8): 1458-1464.
|
| [25] |
Antonopoulos AS, Margaritis M, Lee R， et al. Statins as anti- in？ammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials[J]. Curr Pharm Des，2012，18(11): 1519-1530.
|
| [26] |
Albert M A, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on c-reactive protein levels: the pravastatin in ammation/crP evaluation (Prince): a randomized trial and cohort study[J]. JAMA，2001，286(1): 64-70.
|
| [27] |
Blechacz B, Komuta M, Roskams T，et al. Clinical diagnosis and staging of cholangiocarcinoma[J]．Nat Rev Gastroenterol Hepatol，2011, 8(9): 512-522.
|
| [28] |
Shin HR, Oh JK, Masuyer E，et al.Epidemiology of cholangiocarcinoma: an update focusing on risk factors[J]．Cancer Sci，2010，101(3): 579-585.
|
| [29] |
Peng Yc, lin cl, Hsu WY，et al. Statins are associated with a reduced risk of cholangiocarcinoma：a population-based case-control study[J]. Br J Clin Pharmacol，2015，80(4): 755-761.
|
| [30] |
Ferlay J, Soerjomataram I, Dikshit R，et al. Cancer incidence and mortality worldwide: sources，methods and major patterns in GLOBOCAN 2012[J] .Int J Cancer，2015，136(5): E359-E386.
|
| [31] |
Hee Seung Lee, Sang Hoon Lee, Hyun Jik Lee，et al. Statin Use and Its Impact on Survival in Pancreatic Cancer Patients[J]．Medicine，2016，95(19): 1-7.
|
| [32] |
Wu BU, Chang J, Jeon CY，et al. Impact of statin use on survival inpatients undergoing resection for early-stage pancreatic cancer[J]. Am J Gastroenterol，2015，110(8): 1233-1239.
|
| [33] |
E Jian-Yu, Judith M. Graber，Shou-En Lu，et al. Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Metaanalysis[J]．Curr Med Chem，2018，25(22): 2595-2607.
|
| [34] |
Zhang Yun, Liang Mingming, Sun Chenyu，et al. Statin Use and Risk of Pancreatic Cancer An Updated Meta-analysis of 26 Studies[J]. Pancreas，2019，48(2): 142-150.
|
| [35] |
Fitzmaurice c, allen c, Barber rM，et al. global，regional，and national cancer incidence，mortality，years of life lost，years lived with disability，and disability adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study[J]. JAMA Oncol, 2017，3(4): 524-548.
|
| [36] |
Cai H, Zhang G, Wang Z，et al. Relationship Between the Use of Statins and Patient Survival in Colorectal Cancer: A Systematic Review and Meta-Analysis[J]．PLoS ONE，2015，10(6): e0126944.
|
| [37] |
Hiroshi Yokomichi, Akiko Nagai, Makoto Hirata，et al. Statin use and all-cause and cancer mortality：BioBank Japan cohort[J]．J Epidemiol，2017，27(3): 84-91.
|
| [38] |
Małgorzata Dobrzycka, Piotr Spychalski, Andrzej J. achiński，et al. Statins and Colorectal Cancer - A Systematic Review[J]．Exp Clin Endocrinol Diabetes，2018，25(4): 1-8.
|
|
cheung Ka-Shing, chen lijia, esther W chan，et al. Statins reduce the progression of non-advanced adenomas to colorectal cancer: a postcolonoscopy study in 187897 patients[J]. Gut ，2019，68(2): 1-7.
|